LiquiBand® Exceed™ XS

LiquiBand® Exceed™ XS offers the improved attributes of precision and controlled delivery with added advantages of an innovative tip design.

 

Description

Key Benefits

High Viscosity3

  • Provides optimal flexibility

Controlled expression of adhesive4

  • Applicator offers control during expression of adhesive

Microbial barrier5

  • Acts as a barrier against gram-positive, gram-negative and fungal microbes. Proven effectiveness against S. aureus, P.aeruginosa, E.coli, Candida albicans and MRSA

No Clog Formulation6

  • Allows users to work at their own pace

  • One applicator covers 7cm of wound length

Maintains wound closure throughout healing process7

  • The adhesive will stay on the skin for 5-10 days and sloughs off naturally

 

 

Giving protection against:

 

Gram Positive Bacteria Gram Negative Bacteria Fungi
> S. Epidermidis > Ps. Aeruginosa > Asp. Brasiliensis (niger)
> S. Aureus & MRSA > E. Coli > C. Albicans
  > E. Cloacae  

Design Features

Pure octyl formulation

  • Maximises durability and flexibility

  • Provides high viscosity

  • Creates intimate skin contact

Unique applicator tip

  • Elliptical shape allows for narrow or wide application

  • Porous felt tip allows drip-free priming and even, consistent application

Easy to use applicator

  • Winged applicator allows for safe and easy activation

  • Provides controlled delivery of adhesive

No clog technology

  • Tip will not clog, allowing consistent flow of adhesive

  • 0.4mL of adhesive per applicator delivers approximately 7cm of coverage

 

 

 

 

 

 

 

 

References 1-6, 9. Data on file at Advanced Medical Solutions (Plymouth) Ltd. 7: Dowson CC, A prospective, randomized controlled trial comparing n-butyl cyanoacrylate tissue adhesive (LiquiBand) with sutures for skin closure after laparoscopic general surgical procedures. Surg Laparosc Endosc Percutan Tech. 2006 Jun;16(3):146-50. 8: Gorozpe-Calvillo JI, Closure of the skin with cyanoacrylate in cesarean section. Ginecol Obstet Mex. 1999 Oct;67:491-6